To ask the Minister of Health, pursuant to AQW 31823/22-27, to detail what measures are in place to ensure consistent and equitable access to BRCA1 and BRCA2 genetic testing.

I can confirm that my Department is committed to ensuring consistent and equitable access to BRCA1 and BRCA2 genetic testing across Northern Ireland. The Northern Ireland Regional Genetics Service receives referrals from both primary and secondary care providers from across the region, operating outreach clinics and virtual clinics to provide equitable access across Northern Ireland. Patients and families affected by breast and ovarian cancer are assessed using UK-wide clinical guidelines. Eligibility for BRCA1 and BRCA2 testing is determined in accordance with the National Genomics Test Directory, which provides clear and consistent criteria for genomic testing. The National Genomics Test Directory, developed by the Test Evaluation Working Group, includes representation from all UK devolved nations, including Northern Ireland, to ensure that regional needs are considered in the development of national testing policies.

In addition, the Regional Genetics Service has established Molecular Tumour Boards and has dedicated clinic capacity to assess genetic variants identified through tumour sequencing that may also be present in the germline. The service is planning a systematic rollout of this approach, starting with ovarian cancers and eventually breast cancers, with the aim of improving the detection of familial cancer cases.

These measures collectively aim to ensure that individuals in Northern Ireland have equitable access to BRCA1 and BRCA2 genetic testing, particularly those with a relevant family history or clinical indication.